Covidien (COV) Tops Q1 EPS by 4c; Boosts FY13 Sales Outlook
Tweet Send to a Friend
Covidien (NYSE: COV) reported Q1 EPS of $1.10, $0.04 better than the analyst estimate of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
